These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24089457)

  • 1. Seropositivity to Helicobacter pylori and risk of pancreatic cancer.
    Yu G; Murphy G; Michel A; Weinstein SJ; Männistö S; Albanes D; Pawlita M; Stolzenberg-Solomon RZ
    Cancer Epidemiol Biomarkers Prev; 2013 Dec; 22(12):2416-9. PubMed ID: 24089457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicobacter pylori seropositivity as a risk factor for pancreatic cancer.
    Stolzenberg-Solomon RZ; Blaser MJ; Limburg PJ; Perez-Perez G; Taylor PR; Virtamo J; Albanes D;
    J Natl Cancer Inst; 2001 Jun; 93(12):937-41. PubMed ID: 11416115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity.
    Kamangar F; Dawsey SM; Blaser MJ; Perez-Perez GI; Pietinen P; Newschaffer CJ; Abnet CC; Albanes D; Virtamo J; Taylor PR
    J Natl Cancer Inst; 2006 Oct; 98(20):1445-52. PubMed ID: 17047193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori infection, chronic corpus atrophic gastritis and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort: A nested case-control study.
    Huang J; Zagai U; Hallmans G; Nyrén O; Engstrand L; Stolzenberg-Solomon R; Duell EJ; Overvad K; Katzke VA; Kaaks R; Jenab M; Park JY; Murillo R; Trichopoulou A; Lagiou P; Bamia C; Bradbury KE; Riboli E; Aune D; Tsilidis KK; Capellá G; Agudo A; Krogh V; Palli D; Panico S; Weiderpass E; Tjønneland A; Olsen A; Martínez B; Redondo-Sanchez D; Chirlaque MD; Hm Peeters P; Regnér S; Lindkvist B; Naccarati A; Ardanaz E; Larrañaga N; Boutron-Ruault MC; Rebours V; Barré A; Bueno-de-Mesquita HB; Ye W
    Int J Cancer; 2017 Apr; 140(8):1727-1735. PubMed ID: 28032715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori infection, atrophic gastritis, and risk of pancreatic cancer: A population-based cohort study in a large Japanese population: the JPHC Study.
    Hirabayashi M; Inoue M; Sawada N; Saito E; Abe SK; Hidaka A; Iwasaki M; Yamaji T; Shimazu T; Tsugane S
    Sci Rep; 2019 Apr; 9(1):6099. PubMed ID: 30988344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study of Helicobacter pylori in relation to the risk for pancreatic cancer.
    Lindkvist B; Johansen D; Borgström A; Manjer J
    BMC Cancer; 2008 Nov; 8():321. PubMed ID: 18986545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori seropositivity and risk of lung cancer.
    Koshiol J; Flores R; Lam TK; Taylor PR; Weinstein SJ; Virtamo J; Albanes D; Perez-Perez G; Caporaso NE; Blaser MJ
    PLoS One; 2012; 7(2):e32106. PubMed ID: 22384154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: a case-control study.
    Risch HA; Yu H; Lu L; Kidd MS
    J Natl Cancer Inst; 2010 Apr; 102(7):502-5. PubMed ID: 20181960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between Helicobacter pylori and pancreatic cancer risk: a meta-analysis.
    Schulte A; Pandeya N; Fawcett J; Fritschi L; Risch HA; Webb PM; Whiteman DC; Neale RE
    Cancer Causes Control; 2015 Jul; 26(7):1027-35. PubMed ID: 25951801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of helicobacter pylori infection and chronic atrophic gastritis with risk of colonic, pancreatic and gastric cancer: A ten-year follow-up of the ESTHER cohort study.
    Chen XZ; Schöttker B; Castro FA; Chen H; Zhang Y; Holleczek B; Brenner H
    Oncotarget; 2016 Mar; 7(13):17182-93. PubMed ID: 26958813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori seropositivities and risk of pancreatic carcinoma.
    Risch HA; Lu L; Kidd MS; Wang J; Zhang W; Ni Q; Gao YT; Yu H
    Cancer Epidemiol Biomarkers Prev; 2014 Jan; 23(1):172-8. PubMed ID: 24234587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Helicobacter pylori infection in pancreatic cancer].
    Gawin A; Wex T; Ławniczak M; Malfertheiner P; Starzyńska T
    Pol Merkur Lekarski; 2012 Feb; 32(188):103-7. PubMed ID: 22590913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Antiparietal Cell and Anti-Intrinsic Factor Antibodies With Risk of Gastric Cancer.
    Song M; Camargo MC; Katki HA; Weinstein SJ; Männistö S; Albanes D; Surcel HM; Rabkin CS
    JAMA Oncol; 2022 Feb; 8(2):268-274. PubMed ID: 34913949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicobacter pylori Seropositivity, ABO Blood Type, and Pancreatic Cancer Risk From 5 Prospective Cohorts.
    Lee AA; Wang QL; Kim J; Babic A; Zhang X; Perez K; Ng K; Nowak J; Rifai N; Sesso HD; Buring JE; Anderson GL; Wactawski-Wende J; Wallace R; Manson JE; Giovannucci EL; Stampfer MJ; Kraft P; Fuchs CS; Yuan C; Wolpin BM
    Clin Transl Gastroenterol; 2023 May; 14(5):e00573. PubMed ID: 36854058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori infection and development of pancreatic cancer.
    de Martel C; Llosa AE; Friedman GD; Vogelman JH; Orentreich N; Stolzenberg-Solomon RZ; Parsonnet J
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1188-94. PubMed ID: 18483341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum pepsinogen 1 and anti-Helicobacter pylori IgG antibodies as predictors of gastric cancer risk in Finnish males.
    Song M; Camargo MC; Weinstein SJ; Murphy G; Freedman ND; Koshiol J; Stolzenberg-Solomon RZ; Abnet CC; Männistö S; Albanes D; Rabkin CS
    Aliment Pharmacol Ther; 2018 Feb; 47(4):494-503. PubMed ID: 29243850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum pepsinogens and Helicobacter pylori in relation to the risk of esophageal squamous cell carcinoma in the alpha-tocopherol, beta-carotene cancer prevention study.
    Cook MB; Dawsey SM; Diaw L; Blaser MJ; Perez-Perez GI; Abnet CC; Taylor PR; Albanes D; Virtamo J; Kamangar F
    Cancer Epidemiol Biomarkers Prev; 2010 Aug; 19(8):1966-75. PubMed ID: 20647397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori blood biomarker for gastric cancer risk in East Asia.
    Cai H; Ye F; Michel A; Murphy G; Sasazuki S; Taylor PR; Qiao YL; Park SK; Yoo KY; Jee SH; Cho ER; Kim J; Chen SC; Abnet CC; Tsugane S; Cai Q; Shu XO; Zheng W; Pawlita M; Epplein M
    Int J Epidemiol; 2016 Jun; 45(3):774-81. PubMed ID: 27170766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxin-Associated Gene A-Negative Strains of Helicobacter pylori as a Potential Risk Factor of Pancreatic Cancer: A Meta-Analysis Based on Nested Case-Control Studies.
    Chen XZ; Wang R; Chen HN; Hu JK
    Pancreas; 2015 Nov; 44(8):1340-4. PubMed ID: 26390415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum gastrin and cholecystokinin are associated with subsequent development of gastric cancer in a prospective cohort of Finnish smokers.
    Murphy G; Abnet CC; Choo-Wosoba H; Vogtmann E; Weinstein SJ; Taylor PR; Männistö S; Albanes D; Dawsey SM; Rehfeld JF; Freedman ND
    Int J Epidemiol; 2017 Jun; 46(3):914-923. PubMed ID: 28369403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.